Cite
HARVARD Citation
Taylor, M. et al. (2015). Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Taylor, M. et al. (2015). Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].